All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

/images/Cortellis_Flagship_Logo_TM_RGB_Color.png
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • Diagnosing and tracking COVID-19
    • Drugs to Watch 2020
    • The next pandemic
    • Premium reports
      • BioWorld Financings Reports
      • Disease Forecast Reports

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, March 5, 2021
Home » Blogs » BioWorld MedTech Perspectives » Strikeout: Three stories that missed

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

BioWorld MedTech

Strikeout: Three stories that missed

Sep. 4, 2014
By Mark McCarty
No Comments

Reggie: Lots of homers, lots of strikeouts.
Whiff: Reggie hit a lot of homers, but had nearly 2,600 strikeouts.

Baseball analogies are definitely overused, and now it’s my turn to abuse the privilege. Following are three stories in which somebody failed to reach base.

Definition of a device

One of the more interesting developments of late is the recall of a huge number of convenience kits assembled by Customed of Puerto Rico. FDA recently announced a recall of more than 200 of these so-called “devices,” but there’s something a little misleading about characterizing this as a medical device recall.

So a convenience kit is a medical device? The Center for Devices and Radiological Health also regulates laser pointers used during public presentations. Does that make laser pointers medical devices?

When most people think of medical devices, they think about pacemakers, CT units, and infusion pumps. A convenience kit is described as a medical device only because FDA has deemed it as such for regulatory purposes. There is nothing about a convenience kit that qualifies it as a medical device. It’s just not even close.

Drinking the healthcare Kool-Aid

You have to love the propensity of the defenders of the Affordable Care Act to wax euphorically over the recent news regarding healthcare spending growth. The latest news is that healthcare spending growth is expected to top out at 5.7% per annum over the next decade or so. Is this good news?

Well, a lot of pundits seem to think so, based on the notion that this pace will outstrip GDP growth by a mere 1.5%. The problem is that this calls on the economy to grow at 4.2% annually over that time. Is that a realistic expectation?

The data suggest nothing even remotely resembling that kind of GDP growth has happened in the past three-plus decades, as this report makes clear. The average growth of GDP between 1981 and 2000 was in the neighborhood of 3.5%. I’ll give the supporters of the Affordable Care Act a pass on the numbers since 2008 because of this protracted recession, but the numbers just do not add up even if you discount the past six years.

Pioneer ACOs voting with their feet

The news is out that Sharp Healthcare of San Diego just exited the Pioneer accountable care organization plan, but Sharp is not the first Pioneer ACO to dump the program by any means.

It’s tough to extrapolate this to other organizations because one imagines the participants in the Pioneer program were already “doing it right,” so perhaps they had less to gain than others. Still, one has to wonder if the ACO program isn’t in competition with other Medicare programs, such as the bundled payment program, which CMS discussed earlier this year.

We’ve all heard at least informally that the Centers for Medicare & Medicaid Services has more healthcare reform programs in the works than providers can digest. Could these two programs (and others) be cannibalizing each other?

You must login or register in order to post a comment.

Report Abusive Comment

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 4.
  • Gloved hand places sample tubes in PCR system

    COVID-19 test makers are adapting for variants

    BioWorld MedTech
    As COVID-19 variants have emerged, so have questions about the effectiveness of tests for infection. While the risk of mutations significantly limiting their...
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech's briefs for March 4.
  • Celltrion-Regkirona-2-9

    Celltrion wins first conditional Korean approval for COVID-19 antibody Regkirona

    BioWorld
    HONG KONG – Celltrion Inc. has received conditional marketing authorization from the Ministry of Food and Drug Safety (MFDS) for its anti-COVID-19 monoclonal...
cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • About
    • Archives
    • Today's news
    • Search BioWorld Science
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
A Clarivate Analytic solution. Link to Clarivate website.
Follow Us

Copyright ©2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing